Quadrant Capital Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Quadrant Capital Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25	Closed	-$3K	–	2426
2020 Q3	$3K	Sell	25 -7	-22%	-$744	﹤0.01%	1777
2020 Q2	$3K	Sell	32 -624	-95%	-$52.1K	﹤0.01%	1870
2020 Q1	$31K	Buy	656 +5	+0.8%	+$320	0.01%	1111
2019 Q4	$47K	Hold	651	–	–	0.01%	1374
2019 Q3	$33K	Buy	+651	New	+$34.6K	0.01%	1408

Quadrant Capital Group's MYOK Position: Q4 2020 in Review

Quadrant Capital Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 25 shares — an estimated $3K sold.

Quadrant Capital Group first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $47K in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Quadrant Capital Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Quadrant Capital Group sold 25 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3K.
Quadrant Capital Group first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Quadrant Capital Group's MyoKardia, Inc. Common Stock position peaked at $47K in Q4 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Quadrant Capital Group's 13F filing for Q4 2020, filed 16 Feb 2021.